Cytosorbents Total Current Assets from 2010 to 2024

CTSO Stock  USD 0.81  0.01  1.22%   
Cytosorbents Crp Total Current Assets yearly trend continues to be very stable with very little volatility. Total Current Assets are likely to drop to about 17.6 M. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2004-12-31
Previous Quarter
19.3 M
Current Value
25.7 M
Quarterly Volatility
22.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 150 K or Selling General Administrative of 39.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.002 or PTB Ratio of 2.24. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
  
This module can also supplement Cytosorbents Crp's financial leverage analysis and stock options assessment as well as various Cytosorbents Crp Technical models . Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Latest Cytosorbents Crp's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Cytosorbents Crp over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Cytosorbents Crp's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Cytosorbents Total Current Assets Regression Statistics

Arithmetic Mean21,807,440
Geometric Mean8,583,404
Coefficient Of Variation108.34
Mean Deviation16,725,561
Median17,561,561
Standard Deviation23,625,205
Sample Variance558.2T
Range82.4M
R-Value0.63
Mean Square Error362.8T
R-Squared0.40
Significance0.01
Slope3,326,072
Total Sum of Squares7814.1T

Cytosorbents Total Current Assets History

202417.6 M
202325.7 M
202233.8 M
202164.3 M
202082.5 M
201920.9 M
201828.3 M

About Cytosorbents Crp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cytosorbents Crp income statement, its balance sheet, and the statement of cash flows. Cytosorbents Crp investors use historical funamental indicators, such as Cytosorbents Crp's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Cytosorbents Crp investors may use each financial statement separately, they are all related. The changes in Cytosorbents Crp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytosorbents Crp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytosorbents Crp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytosorbents Crp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets25.7 M17.6 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytosorbents Crp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytosorbents Crp's short interest history, or implied volatility extrapolated from Cytosorbents Crp options trading.

Pair Trading with Cytosorbents Crp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cytosorbents Stock

  0.7AHG Akso Health GroupPairCorr

Moving against Cytosorbents Stock

  0.76GCTK GlucoTrackPairCorr
  0.69SNDA Sonida Senior LivingPairCorr
  0.64TNDM Tandem Diabetes Care Financial Report 1st of May 2024 PairCorr
  0.61TLIS Talis Biomedical CorpPairCorr
  0.52JYNT Joint Corp Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Cytosorbents Stock analysis

When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
0.814
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.32)
Return On Equity
(0.97)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.